iShares · 2006-05-01 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$451.7M | — | — | $1.14B | 每日估算 |
| 2026-07-30 | +$131.0M | — | — | $1.61B | 每日估算 |
| 2026-07-29 | +$2.6M | — | — | $1.48B | 每日估算 |
| 2026-07-28 | +$319.9M | — | — | $1.46B | 每日估算 |
| 2026-07-27 | -$4.4M | — | — | $1.14B |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
JOHNSON JOHNSON JOHNSON JOHNSON | EC | 942,632 | $230.4M | 23.03% |
ELI LILLY CO ELI LILLY CO | EC | 229,087 | $210.7M | 21.06% |
MERCK CO INC MERCK CO INC | EC | 394,200 | $47.4M | 4.74% |
PFIZER INC PFIZER INC | EC |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$4.4M | — | — | $1.14B | 每日估算 |
| 2026-07-25 | -$320.6M | — | — | $1.14B | 每日估算 |
| 2026-03-31 | -$4.6M | $13.3M | $17.9M | $1.00B | SEC 月度 |
| 2026-02-28 | +$35.8M | $35.8M | $0 | — | SEC 月度 |
| 2026-01-31 | +$101.6M | $118.6M | $17.1M | — | SEC 月度 |
| 1,678,022 |
| $47.1M |
| 4.71% |
ROYALTY PHARMA PLC ROYALTY PHARMA PLC | EC | 981,152 | $47.1M | 4.70% |
BRISTOL MYERS SQUIBB CO BRISTOL MYERS SQUIBB CO | EC | 763,754 | $46.3M | 4.63% |
ZOETIS INC ZOETIS INC | EC | 382,419 | $45.2M | 4.52% |
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | STIV | 43,573,039 | $43.6M | 4.36% |
VIATRIS INC VIATRIS INC | EC | 3,219,194 | $43.5M | 4.35% |
ELANCO ANIMAL HEALTH INC ELANCO ANIMAL HEALTH INC | EC | 1,388,731 | $33.2M | 3.32% |
JAZZ PHARMACEUTICALS PLC JAZZ PHARMACEUTICALS PLC | EC | 169,838 | $32.1M | 3.21% |
AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC | EC | 118,359 | $20.0M | 2.00% |
TERNS PHARMACEUTICALS INC TERNS PHARMACEUTICALS INC | EC | 240,429 | $12.7M | 1.27% |
LIGAND PHARMACEUTICALS LIGAND PHARMACEUTICALS | EC | 55,011 | $11.0M | 1.10% |
INDIVIOR PHARMACEUTICALS INC INDIVIOR PHARMACEUTICALS INC | EC | 348,967 | $10.6M | 1.06% |
CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC | EC | 261,660 | $10.5M | 1.05% |
CRINETICS PHARMACEUTICALS INC CRINETICS PHARMACEUTICALS INC | EC | 286,520 | $10.4M | 1.04% |
SUPERNUS PHARMACEUTICALS INC SUPERNUS PHARMACEUTICALS INC | EC | 160,263 | $8.3M | 0.83% |
PRESTIGE CONSUMER HEALTH PRESTIGE CONSUMER HEALTH | EC | 132,257 | $7.8M | 0.78% |
TARSUS PHARMACEUTICALS INC TARSUS PHARMACEUTICALS INC | EC | 109,154 | $7.7M | 0.77% |
LIQUIDIA CORP LIQUIDIA CORP | EC | 192,090 | $7.2M | 0.72% |
EDGEWISE THERAPEUTICS INC EDGEWISE THERAPEUTICS INC | EC | 207,131 | $6.5M | 0.65% |
AMNEAL PHARMACEUTICALS INC AMNEAL PHARMACEUTICALS INC | EC | 474,468 | $5.9M | 0.59% |
NEKTAR THERAPEUTICS NEKTAR THERAPEUTICS | EC | 78,204 | $5.6M | 0.56% |
DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC | EC | 275,332 | $5.2M | 0.52% |
ALUMIS INC ALUMIS INC | EC | 226,551 | $5.0M | 0.50% |
ENLIVEN THERAPEUTICS INC ENLIVEN THERAPEUTICS INC | EC | 124,406 | $4.9M | 0.49% |
INNOVIVA INC INNOVIVA INC | EC | 198,530 | $4.6M | 0.46% |
ORGANON CO ORGANON CO | EC | 726,652 | $4.4M | 0.43% |
PERRIGO CO PLC PERRIGO CO PLC | EC | 384,659 | $4.1M | 0.41% |
OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC | EC | 486,759 | $4.1M | 0.41% |
ANI PHARMACEUTICALS INC ANI PHARMACEUTICALS INC | EC | 50,247 | $3.9M | 0.39% |
TREVI THERAPEUTICS INC TREVI THERAPEUTICS INC | EC | 290,306 | $3.5M | 0.35% |
HARROW INC HARROW INC | EC | 92,131 | $3.2M | 0.32% |
AMYLYX PHARMACEUTICALS INC AMYLYX PHARMACEUTICALS INC | EC | 233,280 | $3.2M | 0.32% |
PHIBRO ANIMAL HEALTH CORP PHIBRO ANIMAL HEALTH CORP | EC | 57,644 | $3.2M | 0.32% |
HARMONY BIOSCIENCES HOLDINGS INC HARMONY BIOSCIENCES HOLDINGS INC | EC | 111,077 | $3.1M | 0.31% |
WAVE LIFE SCIENCES LTD WAVE LIFE SCIENCES LTD | EC | 404,066 | $2.9M | 0.29% |
COLLEGIUM PHARMACEUTICAL INC COLLEGIUM PHARMACEUTICAL INC | EC | 88,352 | $2.9M | 0.29% |
NUVATION BIO INC NUVATION BIO INC | EC | 668,795 | $2.9M | 0.29% |
EYEPOINT INC EYEPOINT INC | EC | 217,506 | $2.8M | 0.28% |
XERIS BIOPHARMA HOLDINGS INC XERIS BIOPHARMA HOLDINGS INC | EC | 463,758 | $2.7M | 0.27% |
PACIRA BIOSCIENCES INC PACIRA BIOSCIENCES INC | EC | 114,720 | $2.6M | 0.26% |
RAPPORT THERAPEUTICS INC RAPPORT THERAPEUTICS INC | EC | 79,927 | $2.5M | 0.25% |
MBX BIOSCIENCES INC MBX BIOSCIENCES INC | EC | 70,280 | $2.1M | 0.21% |
OMEROS CORP OMEROS CORP | EC | 198,165 | $2.1M | 0.21% |
AMPHASTAR PHARMACEUTICALS INC AMPHASTAR PHARMACEUTICALS INC | EC | 98,895 | $1.9M | 0.19% |
ARVINAS INC ARVINAS INC | EC | 179,506 | $1.9M | 0.19% |
MAZE THERAPEUTICS INC MAZE THERAPEUTICS INC | EC | 59,177 | $1.8M | 0.18% |
THERAVANCE BIOPHARMA INC THERAVANCE BIOPHARMA INC | EC | 103,389 | $1.7M | 0.17% |
LB PHARMACEUTICALS INC LB PHARMACEUTICALS INC | EC | 67,960 | $1.7M | 0.17% |
PHATHOM PHARMACEUTICALS INC PHATHOM PHARMACEUTICALS INC | EC | 139,379 | $1.5M | 0.15% |
SEPTERNA INC SEPTERNA INC | EC | 63,823 | $1.5M | 0.15% |
BIOAGE LABS INC BIOAGE LABS INC | EC | 84,022 | $1.5M | 0.15% |
CORMEDIX INC CORMEDIX INC | EC | 204,800 | $1.4M | 0.14% |
BLACKROCK CASH FUNDS TREASURY BLACKROCK CASH FUNDS TREASURY | STIV | 901,594 | $901,594 | 0.09% |
EVOLUS INC EVOLUS INC | EC | 181,171 | $744,613 | 0.07% |
LENZ THERAPEUTICS INC LENZ THERAPEUTICS INC | EC | 61,219 | $560,154 | 0.06% |
1XAVM26 XAV HEALTH CARE JUN26 | DE | 8 | -$33,488 | -0.00% |